Jennifer Gabler

Jennifer Gabler serves as Chief Financial Officer at EvolveImmune Therapeutics, leading financial strategies for a company focused on innovative drug development in oncology and immunological diseases. Concurrently, Jennifer works as a Finance Consultant for Allyx Therapeutics, supporting its mission to develop therapeutics for Alzheimer's and Parkinson's Disease. Further experience includes partnership at Marlborough Street Partners, providing strategic services to investors, and consultancy roles across organizations like MSquash, which enhances athlete performance, and Clear Careers, which offers experiential career pathways for students. Jennifer co-founded The Refinery CT, an accelerator for scaling businesses, and held leadership roles at Rochester Point, LLC, Turq LLC, and Columbia Technology Ventures. Educational background includes an MBA in Finance from Columbia Business School and an AB in Economics/Computer Science from Dartmouth College, along with CPA certification in Connecticut.